2007. Ciprofibrate Treatment Decreases Non-high Density Lipoprotein Cholesterol and Triglycerides and Increases High Density Lipoprotein Cholesterol in Patients With Frederickson Type IV Dyslipidemia Phenotype.

Ciprofibrate Treatment Decreases Non-high Density Lipoprotein Cholesterol and Triglycerides and Increases High Density Lipoprotein Cholesterol in Patients With Frederickson Type IV Dyslipidemia Phenotype.
Autores: Bermudez V, Souki A, Cano C, Bermúdez F, Mengual E, Leal E, Lemus M, Cabrera M, Amell A, Leal N, Cano R, Puche G.
Referencia: American Journal of Therapeutics 2007; 14: 213-220.
Ver abstract en línea.